Search Images Maps Play YouTube News Gmail Drive More »
Sign in
Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader.

Patents

  1. Advanced Patent Search
Publication numberUS4979509 A
Publication typeGrant
Application numberUS 07/382,151
Publication dateDec 25, 1990
Filing dateJul 19, 1989
Priority dateJul 19, 1989
Fee statusLapsed
Publication number07382151, 382151, US 4979509 A, US 4979509A, US-A-4979509, US4979509 A, US4979509A
InventorsSaid I. Hakky
Original AssigneeNorthstar Research Institute, Ltd.
Export CitationBiBTeX, EndNote, RefMan
External Links: USPTO, USPTO Assignment, Espacenet
Continuous glucose monitoring and a system utilized therefor
US 4979509 A
Abstract
A continuous process for monitoring blood glucose level includes the steps of segregating a clear liquid component of blood from the protein and cells of the blood, wherein the clear liquid component includes the glucose to be monitored; continuously passing the clear liquid in a predetermined path between a light-emitting and a light-detecting device; detecting an optical property of the clear liquid component of the blood and employing the optical property to determine the glucose level in the blood. The invention also relates to the system for carrying out the continuous glucose monitoring process, and to a device for automatically controlling the pressure level in the system as a function of the breathing pattern of a patient in which the system is implanted.
Images(2)
Previous page
Next page
Claims(32)
What is claimed as the invention is:
1. An in situ method of continuously monitoring the glucose level in the body of a patient including the steps of:
locating a filter member within the interior of a blood vessel for direct contact with blood therein;
directing said blood within the vessel through the filter member for filtering a clear liquid component of the blood then in the vessel from the blood cells and proteins therein, said clear liquid component containing the glucose to be monitored;
continuously passing said clear liquid component along a predetermined path outside the vessel and entirely within the body of the patient so that the clear liquid component does not leave the body of the patient;
detecting an optical property of the clear component as it moves along said predetermined path; and
employing information obtained regarding the detected optical property to determine the glucose level in the blood.
2. The method of claim 1 including the step establishing a negative pressure for aiding in separating the clear liquid component of the blood from the blood cells and proteins thereof, and for continuously passing said clear liquid component in said predetermined path.
3. The method of claim 2 including the step of establishing said negative pressure by connecting a pressure regulating device to spaced-apart ribs of the patient, whereby the breathing activity of the patient is employed to establish the desired negative pressure.
4. The method of claim 1 including the step of employing a computer circuit means for calculating the glucose level based upon the optical property of the clear liquid component and transmitting information indicative of the glucose level to a documentation means.
5. The method of claim 4 wherein the documentation means is a receiver located outside the patient's body for receiving data representative of the glucose level in the blood.
6. The method of claim 1 including the step of providing a perceivable signal when the glucose level is at an unacceptable level.
7. The method of claim 6 wherein the step of providing a perceivable signal is carried out by providing an audible signal.
8. The method of claim 6 wherein the step of providing a perceivable signal is carried out by providing a visual read-out of glucose level.
9. The method of claim 1 including the steps of implanting a source of insulin in a patient's body and releasing insulin from said source when the glucose level is too low.
10. A continuous glucose monitoring system for implantation within the body of a patient to be employed by the patient while the patient is mobile, said system including:
microporous filter means configured for disposition within the interior of a blood vessel of the patient for direct contact with the blood therein for permitting a clear liquid component of the blood then within the vessel to filter through said filter means, said clear liquid component being separated from the blood cells and proteins of said blood and including the glucose to be monitored;
conduit means having a passage for receiving a flow of the clear liquid component from the filter means;
optical detecting means for detecting an optical property of the clear liquid component of the blood, said optical detecting means being disposed adjacent the passage in the conduit means through which the clear liquid component flows;
measuring means for determining the glucose level in the blood based on the detected optical property of the clear liquid component without the clear liquid component having to leave the body of the patient; and
regulating means for controlling the flow of liquid through the passage in the conduit means and past the optical detecting means.
11. The system of claim 10, further including insulin retaining means implanted within the body of the patient and means for releasing insulin from the retaining means when the glucose level in the blood is too low.
12. The system of claim 10 wherein the optical detecting means detects an optical property of the clear liquid fluid representative of the glucose level in the fluid, and said measuring means includes computer circuit means for calculating the glucose level based upon the detected, optical property.
13. The system of claim 12 wherein the optical detecting means is located in a wall of the conduit means and is adapted to engage the clear liquid component flowing through the passage in the conduit means.
14. The system of claim 12 wherein said regulating means includes a pressure regulating member and means for connecting said pressure regulating member to the ribs of a patient, whereby the breathing activity of the patient aids in regulating the pressure in the system.
15. The system of claim 14 wherein said pressure regulating means includes a bellows, and said means for connecting the bellows to the ribs includes adjustable hook means adjacent opposed ends of said bellows.
16. The system of claim 10 further including documentation means attachable externally of the patient's body, said measuring means including means for transmitting to said documentation means information representative of the glucose level in the blood.
17. The system of claim 16 wherein said documentation means includes means for emitting a perceivable signal when the glucose level is at an undesired level.
18. The system of claim 16 wherein said means for emitting a perceivable signal emits a audible signal.
19. The system of claim 16, wherein said documentation means includes a receiver, and wherein a modulator means is employed for transmitting information regarding blood glucose level from the measuring means to the documentation means.
20. The system of claim 16 wherein said means for emitting a perceivable signal emits a visual signal.
21. The system of claim 20 wherein said means for emitting a visual signal emits a read-out of the glucose level.
22. In a method of continuously monitoring glucose level in the body of a patient, the steps of:
locating a filter member within the interior of a blood vessel for direct contact with blood therein;
directing a clear liquid component of the blood through the filter member for separating the clear liquid component from the blood cells and proteins of the blood then within the vessel, said clear liquid component containing the glucose to be monitored and being confined within a path located entirely within the body of the patient; and
monitoring the glucose level in the clear liquid component by means located entirely within the body of the patient so that the clear liquid component does not have to leave the body of the patient during the monitoring thereof.
23. The method of claim 22 wherein the filter member is a hollow member, including the steps of filtering the clear liquid component of the blood into the hollow interior of the filter member and thereafter removing the clear liquid component from the hollow interior of the filter member to a location within the patient's body, but remote from the patient's blood vessel, at which the step of monitoring the glucose level takes place.
24. The method of claim 22 including the step of establishing a pressure deferential across the filter member for aiding in directing the clear liquid component of the blood through the filter member and for directing said clear liquid component out of the blood vessel to a location within the patient's body at which the glucose level in the clear liquid component is monitored.
25. The method of claim 24 including the step of establishing said pressure differential by connecting a pressure regulating device to internal, moving parts of the patient, whereby movement of said parts is employed to establish said pressure differential.
26. The method of claim 25, including the steps of connecting the pressure regulating device to spaced-apart ribs of the patient, whereby the breathing activity of the patient is employed to establish said pressure differential.
27. In a glucose monitoring system to be implanted within the body of a patient to be employed by the patient while the patient is mobile, a microporous filter means configured for disposition within a blood vessel of the patient for direct contact with blood therein for permitting a clear liquid component of the blood to filter through said filter means, said clear liquid component being separated from the blood cells and proteins of said blood and containing the glucose to be monitored, said microporous filter means for providing the clear liquid component into a path located entirely within the body of the patient outside of the vessel in which the glucose level is to be monitored so that the clear liquid component does not have to leave the body of the patient during the monitoring thereof.
28. The system of claim 27 including means for establishing a pressure differential through said microporous filter means for directing the clear liquid component of the blood through said filter means.
29. The system of claim 27 wherein said microporous filter means is a hollow filter member having a continuous, microporous wall, whereby the clear liquid component of the blood is directed through said microporous wall into the hollow interior of said filter member.
30. The system of claim 29 including means for establishing a pressure differential through said filter member for directing the clear liquid component of the blood through said filter member.
31. The system of claim 28 wherein the means for establishing a pressure differential is secured to internal, movable parts of the patient's body.
32. The system of claim 30 wherein the means for establishing a pressure differential is secured to internal, movable parts of the patient's body.
Description
FIELD OF THE INVENTION

This invention relates generally to a method of continuously monitoring glucose levels in the blood, and to a system employed to carry out that method.

BACKGROUND ART

The most commonly used method for detecting and treating diabetic patients, especially type I diabetics, (insulin dependent diabetes mellitus) is for the patient to provide the hospital, doctor or laboratory technician with a specimen of urine or blood, which is then analyzed with a chemistrip to determine the level of glucose in the blood. This is not a continuous monitoring system to specifically advise a patient when it is necessary for him or her to take insulin.

A technique disclosed for the continuous monitoring of blood glucose level is disclosed in U.S. Pat. No. 4,014,321, issued to March. In accordance with the technique described in the March '321 patent polarized light is passed through the body fluids in the eye, and the optical rotation of the light, which is a measure of the glucose concentration, is then detected. The detected output is then directed by a transmitting circuit to a suitable readout device. Another patent which discloses a system for examining the body fluids in the eye to determine the blood glucose level of a patient is U.S. Pat. No. 3,963,019, issued to Quandt. The problem associated with relying upon an examination of eye fluids to determine glucose level is that such fluid is not in equilibrium with that of the blood. In fact, it may take ten (10) to twenty (20) minutes for the fluid to reach a state of equilibrium with the blood. Thus, the glucose level determined through use of the clear fluid secretions in the eye are not as reliable as are often desired.

OBJECTS OF THE INVENTION

It is a general object of this invention to provide a continuous and reliable method of monitoring blood glucose in diabetic patients.

It is a further object of this invention to employ clear body fluids in equilibrium with the blood for the purpose of reliably determining blood glucose level.

It is a further object of this invention to provide a reliable system for controlling the internal pressure in the sampling and measuring parts of the system employed for the continuous monitoring of blood glucose level.

It is a further object of this invention to provide a regulating device, operable by the normal breathing pattern of a patient, for controlling the pressure levels in the system utilized for monitoring the blood glucose level of the patient.

It is a further object of this invention to employ a telemetry arrangement as part of the blood glucose monitoring system to continuously document blood glucose levels transmitted from the measuring part of the system.

It is a more specific object of this invention to provide a blood glucose monitoring system including a sampling section for separating the glucose component of the blood from the blood cells and protein in the blood, a measuring section for measuring the glucose level separated from the blood; a regulating section for controlling the pressure in the sampling part and measuring part within desired limits and a documentation section for documenting the glucose levels determined by the measuring part of the system.

SUMMARY OF THE INVENTION

The above and other objects of this invention are achieved in a continuous method for monitoring blood glucose level including the steps of segregating a clear liquid component of blood from other components of the blood, said clear liquid component including the glucose to be measured; continuously passing said clear liquid component in a predetermined path between a light-emitting and a light-detecting system; and employing information obtained by the light-detecting system to determine the glucose level in the blood.

In accordance with the preferred method of this invention the clear liquid is separated from the protein and cells of the blood by inserting a micro-porous filter member directly into a blood vessel of the patient, wherein the clear component containing the glucose is in equilibrium with the blood. Thus, in accordance with this preferred method a reliable measure of blood glucose level is obtained.

In accordance with a preferred system of this invention a regulating member is provided for establishing a desired negative pressure level to cause the clear liquid component to be filtered from the protein and cells of the, blood, and to be continuously directed past a light-emitting and light-detecting system. This regulating system preferably is controlled by the breathing activity of the patient. Specifically, in the preferred form of this invention the pressure regulating section of the system includes a bellows in fluid communication with the fluid sampling and fluid measuring parts of the system, and this bellows is connected between spaced-apart ribs of the patient, whereby the normal breathing activity of the patient causes movement of the patient's ribs, and the bellows connected thereto, to create the desired pressure conditions within the system.

Also, in accordance with the preferred embodiment of this invention the pressure regulating section of the system is valved to direct the clear liquid component of the blood, after the glucose level therein has been measured, to subcutaneous or muscle tissue in the body.

BRIEF DESCRIPTION OF THE DRAWINGS

Other objects and many of the attendant advantages of this invention will be readily appreciated as the same become better understood by reference to the following detailed description when considered in connection with the accompanying drawings wherein:

FIG. 1 is a schematic, fragmentary view illustrating a continuous glucose monitoring system in accordance with this invention, and positioned within the body of a patient for providing the glucose monitoring function;

FIG. 2 is an enlarged elevational view, partly in section, illustrating the sampling, measuring and regulating sections of the glucose monitoring system;

FIG. 3 is a fragmentary sectional view of the regulating section of the glucose monitoring system illustrated in FIG. 2, but showing the arrangement of valves therein during a different portion of the patient's breathing cycle;

FIG. 4 is an enlarged elevational view of a part of the regulating section of the system, illustrating the arrangement for connecting the regulating system to the ribs of a patient.

DESCRIPTION OF THE PREFERRED EMBODIMENT OF THE INVENTION

Referring now in greater detail to the various figures of the drawings, wherein like reference characters refer to like parts, a continuous glucose monitoring system embodying the present invention is generally shown at 10 in FIG. 1. This system basically comprises a sampling section 12, wherein liquid containing the glucose to be measured is separated from the cells and protein in the blood, a measuring section 14 in which the glucose level is measured, a regulating section 16 for controlling pressure conditions within the system and fox expelling the liquid back to body tissues, and a documentation section 18, which preferably is a telemetry system in the form of a receiver for receiving and storing blood glucose level information.

Referring specifically to FIGS. 1 and 2, the sampling section 12 preferably is in the form of a hollow micro-tube 20 which is inserted directly into a major blood vessel, such as the subclavian vein 21. These hollow micro-tubes 20 are well known in the medical field, and have been employed for years in hemodialysing patients with renal failure disease. In hemodialysing patients these micro-tubes are employed as a fine filter media to remove excess water, potassium chloride and sodium chloride together with creatinine and other low molecular weight materials, such as glucose.

It is important in the present invention that the hollow micro-tube 20 that is employed does not have a pore size to permit the cells or proteins in the blood to pass through it. When the hollow micro-tube 20 is inserted into the subclavian vein in accordance with this invention, a clear fluid component passes from the blood into the hollow interior of the tube, and this clear liquid component contains the moderately low molecular weight glucose as a component thereof. This clear liquid is well suited for use in determining or measuring the glucose level in the blood, as will be explained in greater detail hereinafter.

The micro-tubes 20 employed in this invention can be purchased from a number of sources, and generally has a radius of 17 to 100 angstroms, a wall thickness varying from 5 to 40 microns, an inside diameter of approximately 200 microns and a length of about 200 mm. These tubes are readily available in the market, since, as indicated above, they have been used for years in dialysis applications. For example, one well-known supplier of these materials is Organon Teknika Corporation, located in Oklahoma City, Okla. The choice and selection of the required micro-tube can easily be made without any undue experimentation.

It also should be pointed out that the insertion of a micro-tube or wire into a major vein of a patient is not new, and actually has been done for years. For example, in the pacemaker art a silastic lead is inserted directly into the subclavian vein and down to the right ventricle of the heart. The other end of the lead is connected to a battery implanted under the skin of the cardiac patient. The diameter of this lead is in the range of 1-2 mm, which is greater than the diameter of the micro-tubes employed in the present invention.

As can be seen best in FIG. 2, the downstream end 22 of the micro-tube is threaded, and also is provided with projecting buttons 24 diametrically opposed to each other. This structural arrangement at the downstream end of the micro-tube is employed to connect the micro-tube into the measuring section 14 of the device. Specifically, the connection to the measuring section 14 is made through a clear, hollow silastic tube 26 having an inside diameter in the range of 250 to 300 microns. This tube includes a threaded inlet 28 and diametrically spaced-apart apertures 30 adjacent thereto, for receiving the threaded region 22 and the diametrically spaced-apart buttons 24, respectively, at the downstream end of the hollow micro-tube 20. It should be understood that other fastening means can be employed within the scope of this invention.

As can be seen best in FIG. 2, a monochromatic light source 32 and a solid-state photocell 34 are both directly embedded into the peripheral wall of the silastic tube 26, in diametrically spaced-apart locations. In this manner the photocell comes into direct contact with the clear liquid fluid of the blood directed through the silastic tube 26 from the interior of the hollow micro-tube 20. In an illustrative embodiment the solid-state photocell 34 can be of any well-known type, such as a lead sulfide cell employing a silicon diode or diode array. In the preferred embodiment the photocell includes a wavelength selector, thus accepting maximum light in the region of glucose optical activity.

Still referring to FIG. 2, the measuring section 14 of the system 10 is housed within a stainless steel casing 35, and also includes a power source 36, computer circuitry 38 and a modulator 40.

The power source 36 preferably is a long-life battery of the type employed in pacemaker systems; having a life in the range of ten to fifteen years. Suitable batteries for use in the present invention are lithium iodide batteries, lithium cupric sulfide batteries and lithium silver chromate batteries.

The computer circuit 38 is powered from the power source 36 and is connected to the photocell system to pulse the monochromatic light source 32 in the range of one to fifteen minute intervals. The precise pulse rate can be programmed on a day to day basis using the telemetry of the system. For example, the computer circuit 38 can be programmed by the telemetry to measure the blood glucose level at two minute intervals, by the computer energizing the light source 32 at such two minute intervals. The photocell 34 will then measure the optical rotation of the light, as it passes through the fluid, and the computer circuitry will calculate the concentration of glucose using the following equation: ##EQU1## The computer circuit will then transmit, through the modulator 40, information representing the glucose concentration directly to the receiver 18, with the rate of transmission being at the aforementioned two minute intervals.

The computer circuit 38 is programmed to transmit an alarm signal to the receiver 18, which is located outside the body, if the blood glucose level is below a predetermined level, e.g., 70 mgm percent, or above a predetermined level, e.g., 180 mgm percent, an audible alarm, which is transmitted through speaker 19 of the receiver 18, immediately notifies the patient that his or her blood glucose level is at an abnormal or undesired level.

Referring to FIGS. 2 and 3, the regulating section 16 is of a unique construction, and is designed to maintain a negative pressure in the range of from about 10-20 mm of mercury through the hollow micro-tube 20 and the hollow silastic tube 26, to thereby provide a desired flow rate past the light source 32 and photocell 34 to permit the glucose concentration to be determined. In accordance with a preferred method of this invention the pressure conditions are set to provide an average flow rate of 0.009 cubic centimeters per minute, which is a sufficiently slow rate for an accurate measurement of the blood filtrate to be taken. It should be pointed out herein that the filtrate, being free of protein and blood cells, will not thrombose, and is a colorless clear liquid suitable for utilizing its optical properties to measure the blood glucose level thereof.

As can be seen best in FIGS. 2 and 3, the regulating section 16 includes a bellows 50 which is connected into the silastic tube 26, and is separated from the tube at upstream and downstream ends thereof by a one-way proximal valve 52 and a one-way distal valve 54, respectively. As will be explained in greater detail hereinafter, the bellows 50 actually is connected to the ribs of the patient so that the breathing function of the patient is relied upon to operate the bellows, which in conjunction with the valves 52 and 54 establishes, the desired negative pressure conditions within the glucose monitoring system 10.

During inspiration by a patient the bellows 50 and valves 52 and 54 are as shown in FIG. 2, with the one-way valve 54 at the distal end of the bellows closed, thus preventing outside fluid from entering the glucose monitor. In addition this creates the desired negative pressure needed for filtration.

During expiration by a patient the bellows 50 and valves 52 and 54 are as shown in FIG. 3, with the proximal one way valve 52 closed, thus preventing the fluid in the bellows from returning to the measuring section 14 of the system. In this condition the distal valve 54 opens and expels the liquid content inside the bellows to the subcutaneous or muscular tissue. In this regard it should be noted that the whole glucose sensor system 10, except for receiver 18, is implanted under the skin.

In the preferred embodiment of this invention a pressure release valve 56 is provided adjacent the upstream end of the bellows and is designed to open in the event that the pressure within the silastic tube 26 exceeds 20 mm of mercury. It is apparent that this relief valve is important to prevent an undesired rupturing of the system, in the event that an excessive pressure build-up occurs.

During heavy exercise the amount of pressure inside the bellows 50 can reach the maximum of 20 mm of mercury, due to rapid breathing. Thus, more fluid will be filtered, should the need to measure the blood glucose at one minute intervals arise. On the other hand during sleep, respiration is slower, and the bellows 50 will be moved at a slower rate to reduce the volume of fluid being filtered per unit of time. In this latter condition the filtration pressure will be in the range of about 10 mm of mercury. It also should be noted that the fluid expelled into the muscle or subcutaneous tissue will be absorbed immediately by the body, since it contains no proteins and no blood cells.

From the above explanation it should be apparent that the regulatory section 16 provides two roles; namely, maintaining a negative pressure inside the hollow tubes of the system 10, thus assisting in filtration, and expelling the fluid passing through the measuring section 14 out of the glucose monitoring system 10, thus achieving continuous movement and measurement of blood glucose level.

Turning specifically to FIG. 4, the arrangement for connecting the bellows 50 to the ribs of a patient is illustrated. Specifically, horizontally oriented, flat members 60 and 62 are connected to opposite ends of the bellows 50 and extend between adjacent ribs 64 and 66. These members 60 and 62 are firmly attached to vertical guide rods 68 and 70, respectively, such as by welds. One end of each of the guide rods 68 and 70 is slidably received within a connecting sleeve 72 to permit relative vertical movement between the guide rods and between the plates 60 and 62 connected thereto, as a patient breathes, as will be explained in greater detail hereinafter.

Still referring to FIG. 4, the ends of the guide rods 68 and 70 remote from connecting sleeve 72 include compressible detents 74 which are receivable within complementary passages 76 extending through the side walls 78 of respective hollow hook members 80 and 82. The passages 76 preferable are spaced apart from each other at one (1) centimeter increments. The hook members 80 and 82 are vertically positioned on the guide rods 68 and 70, through the cooperation of detents 74 and complementary passages 76, so that the upper rib is closely confined between horizontal plate 60 and the upper hook section of the hook member 80, and the lower rib 66 is closely confined between the lower horizontal plate 62 and the lower hook section of the hook member 82.

In operation, as a patient inhales, thereby causing the ribs 64 and 66 to move apart, the engagement of the hook members 80 and 82 with the ribs will cause the bellows 50 to expand. Conversely, when the patient exhales, the ribs 64 and 66 will move toward each other, thereby engaging the horizontal plates 60 and 62 to compress the bellows 50. Thus, repeated breathing cycles of the patient sequentially expands and contracts the bellows 50 to and in controlling the pressure within the glucose monitoring system 10.

Referring specifically to FIG. 1, the receiver 18 of the system 10 can be similar to any of the well-known receivers employed as part of a paging system. If desired the receiver can be adapted to be secured around a patient's belt or also can be part of a piece of jewelry, such as a bracelet. The receiver can include a computer memory system for storing blood glucose levels over a 4 to 6 week period, so as to provide a continuous documentation of a patient's glucose level over that period of time.

In operation the modulator 40 of the measuring section 14 (FIG. 2) modulates the signals provided by the computer circuit 38 so that these signals can be transmitted as conventional FM signals to the receiver 18. The receiver includes a conventional tuner which can be set to receive the transmitted signal at the required frequency, and a demodulator to separate the transmitted signals representative of the glucose level from the FM carrier wave.

In accordance with this invention the diabetic patient may actually bring the receiver 18, with the glucose level information therein, to his doctor at the end of the 4 to 6 week period during which the data was stored in the receiver, or alternatively, may communicate the data directly to his attending physician via the telephone wires. In this latter case the receiver 18 also includes a suitable transmitter for modulating the stored signals and transmitting them over the telephone lines to the attending physician. This enables an attending physician to closely monitor his patient, without the need to see the patient on a frequent basis.

In the preferred embodiment of this invention the documentation section 18 includes a warning signal in the event that the blood sugar level in the patient drops below a predetermined level, e.g., 70 mgm percent, or rises above a predetemined level, e.g., 180 mgm percent. This warning signal can be in the form of a beeper signal, transmitted through the speaker 19 of the receiver 18, and also can include a read-out of the glucose level on a screen section 21 of the receiver 18.

It also is within the scope of this invention to connect the documentation section 18 directly to an insulin pump implanted within the body of the diabetic patient's and, through a control switch 23 of the documentation section 18, change the documentation section to a control member for operating the insulin pump to inject insulin into the patient, in the event that the blood sugar level of the patient drops below a predetermined minimum level.

There are many types of telemetry devices available on the market which differ very little from each other, and generally employ the same principal of operation as described herein. The choice of the desired telemetry device is well within the skill in the art, and no further elaboration is believed to be necessary herein.

Without further elaboration, the foregoing will so fully illustrate my invention that others may, by applying current or future knowledge, adopt the same for use under various conditions of service.

Patent Citations
Cited PatentFiling datePublication dateApplicantTitle
US3512517 *Nov 30, 1964May 19, 1970Beckman Instruments IncPolarographic method and apparatus for monitoring blood glucose concentration
US4055175 *May 7, 1976Oct 25, 1977Miles Laboratories, Inc.Blood glucose control apparatus
US4183247 *May 1, 1978Jan 15, 1980Geomet, IncorporatedMethod for sampling air in proportion to respiration
US4206755 *Apr 18, 1978Jun 10, 1980Association Pour La Recherche Et Le Developpement Des Methodes Et Processus Industriels A.R.M.I.N.E.S.Method and apparatus for the control and regulation of glycemia
US4403984 *Dec 22, 1980Sep 13, 1983Biotek, Inc.System for demand-based adminstration of insulin
US4464170 *Sep 29, 1982Aug 7, 1984Miles Laboratories, Inc.Blood glucose control apparatus and method
US4633878 *Apr 10, 1984Jan 6, 1987Guiseppe BombardieriDevice for the automatic insulin or glucose infusion in diabetic subjects, based on the continuous monitoring of the patient's glucose, obtained without blood withdrawal
US4685463 *Apr 3, 1986Aug 11, 1987Williams R BruceDevice for continuous in vivo measurement of blood glucose concentrations
US4703756 *May 6, 1986Nov 3, 1987The Regents Of The University Of CaliforniaDifferential measurement, oxygen sensors, glucose oxidase
US4777953 *Feb 25, 1987Oct 18, 1988Ash Medical Systems, Inc.Capillary filtration and collection method for long-term monitoring of blood constituents
Referenced by
Citing PatentFiling datePublication dateApplicantTitle
US5109850 *Aug 12, 1991May 5, 1992Massachusetts Institute Of TechnologyAutomatic blood monitoring for medication delivery method and apparatus
US5188109 *May 30, 1991Feb 23, 1993Shigeru SaitoArtificial dental root
US5995860 *Jul 6, 1995Nov 30, 1999Thomas Jefferson UniversityImplantable sensor and system for measurement and control of blood constituent levels
US6049727 *Apr 3, 1998Apr 11, 2000Animas CorporationImplantable sensor and system for in vivo measurement and control of fluid constituent levels
US6122536 *Jul 8, 1996Sep 19, 2000Animas CorporationImplantable sensor and system for measurement and control of blood constituent levels
US6505059Apr 6, 1999Jan 7, 2003The General Hospital CorporationNon-invasive tissue glucose level monitoring
US6721582Feb 20, 2001Apr 13, 2004Argose, Inc.Non-invasive tissue glucose level monitoring
US6728560Feb 28, 2002Apr 27, 2004The General Hospital CorporationNon-invasive tissue glucose level monitoring
US6885881Jan 8, 2002Apr 26, 2005Steffen LeonhardtDevice for measuring human blood sugar levels
US6968375Sep 8, 2000Nov 22, 2005Health Hero Network, Inc.Networked system for interactive communication and remote monitoring of individuals
US7167818Mar 16, 2001Jan 23, 2007Health Hero Network, Inc.Disease simulation system and method
US7223235Sep 9, 2005May 29, 2007Health Hero Network, Inc.System and method for monitoring blood pressure from a person
US7223236Sep 9, 2005May 29, 2007Health Hero Network, Inc.System and method for monitoring user-related data from a person
US7252636Jun 13, 2005Aug 7, 2007Health Hero Network, Inc.Networked system for interactive communication and remote monitoring of individuals
US7254429Aug 11, 2004Aug 7, 2007Glucolight CorporationMethod and apparatus for monitoring glucose levels in a biological tissue
US7258666Nov 5, 2004Aug 21, 2007Health Hero Network, Inc.System and methods for monitoring a patient's heart condition
US7260480Apr 7, 2004Aug 21, 2007Health Hero Network, Inc.Method and system for integrating feedback loops in medical knowledge development and healthcare management
US7264591Oct 7, 2003Sep 4, 2007Health Hero Netowrk, Inc.System and method for monitoring air flow from a person
US7297109Dec 12, 2002Nov 20, 2007Health Hero Network, Inc.Method and system for improving adherence with a diet program or other medical regimen
US7305348Jul 25, 2000Dec 4, 2007Health Hero Network, Inc.Aggregating and pooling health related information in a communication system with feedback
US7310668Mar 28, 2005Dec 18, 2007Health Hero Network, Inc.Remotely monitoring an individual using scripted communications
US7320030Mar 28, 2005Jan 15, 2008Health Hero Network, Inc.Remote health monitoring apparatus using scripted communications
US7356365Jul 2, 2004Apr 8, 2008Glucolight CorporationMethod and apparatus for tissue oximetry
US7392167Oct 10, 2006Jun 24, 2008Health Hero Network, Inc.Disease simulation system and method
US7399276May 7, 2004Jul 15, 2008Health Hero Network, Inc.Remote health monitoring system
US7510849Jan 21, 2005Mar 31, 2009Glucolight CorporationUsing optical coherence tomography (OCT) for use in monitoring blood glucose and diagnosing diabetes
US7516192Jul 14, 2006Apr 7, 2009Health Hero Network, Inc.Networked system for interactive communication and remote monitoring of individuals
US7533171Aug 29, 2006May 12, 2009Health Hero Network, Inc.Networked system for interactive communication and remote monitoring of individuals
US7555436Jan 9, 2004Jun 30, 2009Health Hero Network, Inc.Personalized display of health information
US7584108Sep 21, 2006Sep 1, 2009Health Hero Network, Inc.Network media access control system for encouraging patient compliance with a treatment plan
US7587469Jan 29, 2007Sep 8, 2009Health Hero Network, Inc.Audio instructions for appliances
US7590549Sep 21, 2006Sep 15, 2009Health Hero Network, Inc.Network media access control system for encouraging patient compliance with a treatment plan
US7613590Nov 15, 2005Nov 3, 2009Health Hero Network, Inc.Modular microprocessor-based power tool system
US7613621Dec 13, 2006Nov 3, 2009Health Hero Network, Inc.Personalized body image
US7615007Mar 26, 2007Nov 10, 2009Dexcom, Inc.Analyte sensor
US7636667Sep 21, 2006Dec 22, 2009Health Hero Networks, Inc.Network media access control system for encouraging patient compliance with a treatment plan
US7643971Oct 31, 2006Jan 5, 2010Health Hero Network, Inc.Disease simulation system and method
US7679407Apr 27, 2004Mar 16, 2010Abbott Diabetes Care Inc.Method and apparatus for providing peak detection circuitry for data communication systems
US7684999Dec 3, 2004Mar 23, 2010Health Hero Network, Inc.User-based health monitoring
US7689440Nov 22, 2006Mar 30, 2010Health Hero Network, Inc.Method and apparatus for remote health monitoring and providing health related information
US7707270Jul 10, 2006Apr 27, 2010Health Hero Network, Inc.Networked system for interactive communication and remote monitoring of individuals
US7730177May 19, 2005Jun 1, 2010Health Hero Network, Inc.Networked system for interactive communication and remote monitoring of individuals
US7734718Jan 29, 2007Jun 8, 2010Health Hero Network, Inc.Smart appliance functionality
US7756561Sep 30, 2005Jul 13, 2010Abbott Diabetes Care Inc.Method and apparatus for providing rechargeable power in data monitoring and management systems
US7765112Dec 30, 2008Jul 27, 2010Health Hero Network, Inc.Multiple patient monitoring system for proactive health management
US7768408May 17, 2006Aug 3, 2010Abbott Diabetes Care Inc.Method and system for providing data management in data monitoring system
US7769605Aug 23, 2007Aug 3, 2010Health Hero Network, Inc.Multiple patient monitoring system for proactive health management
US7775975Mar 26, 2007Aug 17, 2010Dexcom, Inc.Analyte sensor
US7778845Jul 11, 2006Aug 17, 2010Health Hero Network, Inc.Multiple patient monitoring system for proactive health management
US7814143Dec 13, 2005Oct 12, 2010Health Hero Network, Inc.System and method for modifying documents sent over a communications network
US7822452Apr 13, 2006Oct 26, 2010Glt Acquisition Corp.Method for data reduction and calibration of an OCT-based blood glucose monitor
US7822625Aug 7, 2006Oct 26, 2010Health Hero Network, Inc.Networked system for interactive communication and remote monitoring of individuals
US7827040Sep 16, 2003Nov 2, 2010Health Hero Network, Inc.Patient control of health-related data in a remote patient monitoring system
US7840420Apr 26, 2010Nov 23, 2010Health Hero Network, Inc.Multiple patient monitoring system for proactive health management
US7862506Oct 25, 2007Jan 4, 2011Health Hero Network, Inc.Diabetes management system
US7867165Oct 19, 2006Jan 11, 2011Health Hero Network, Inc.System and method for monitoring a physiological condition
US7869852Oct 26, 2007Jan 11, 2011Health Hero Network, Inc.Diabetes management system
US7870249Jun 12, 2006Jan 11, 2011Health Hero Network, Inc.Networked system for interactive communication and remote monitoring of individuals
US7871376May 14, 2007Jan 18, 2011Health Hero Network, Inc.System and method for monitoring a physiological condition
US7877271May 14, 2007Jan 25, 2011Health Hero Network, Inc.Blood glucose monitoring system
US7877274Sep 16, 2003Jan 25, 2011Health Hero Network, Inc.Messaging to remote patients in a networked health-monitoring system
US7877276Feb 27, 2006Jan 25, 2011Health Hero Network, Inc.Messaging to remote patients in a networked health-monitoring system
US7884729Aug 2, 2010Feb 8, 2011Abbott Diabetes Care Inc.Method and system for providing data management in data monitoring system
US7899518Sep 12, 2005Mar 1, 2011Masimo Laboratories, Inc.Non-invasive tissue glucose level monitoring
US7901625Oct 24, 2007Mar 8, 2011Health Hero Network, Inc.System for performing diabetes self-care
US7904310May 14, 2007Mar 8, 2011Health Hero Network, Inc.Blood glucose monitoring system
US7908152Oct 24, 2007Mar 15, 2011Health Hero Network, Inc.Blood glucose monitoring system
US7921186Feb 14, 2007Apr 5, 2011Health Hero Network, Inc.Networked system for interactive communication and remote monitoring of individuals
US7922458Dec 29, 2008Apr 12, 2011Abbott Diabetes Care Inc.Variable volume, shape memory actuated insulin dispensing pump
US7925522Oct 29, 2009Apr 12, 2011Health Hero Network, Inc.Personalized body image
US7941323Jun 29, 2005May 10, 2011Health Hero Network, Inc.Remote health monitoring and maintenance system
US7941327Dec 3, 2004May 10, 2011Health Hero Network, Inc.User monitoring
US7966230May 14, 2007Jun 21, 2011Health Hero Network, Inc.Method and apparatus for remote health monitoring and providing health related information
US7972267Oct 25, 2007Jul 5, 2011Health Hero Network, Inc.Diabetes management system
US7987100Jul 10, 2006Jul 26, 2011Health Hero Network, Inc.Networked system for interactive communication and remote monitoring of individuals
US7993108Apr 13, 2005Aug 9, 2011Abbott Diabetes Care Inc.Variable volume, shape memory actuated insulin dispensing pump
US7993109Dec 29, 2008Aug 9, 2011Abbott Diabetes Care Inc.Variable volume, shape memory actuated insulin dispensing pump
US8005690Aug 8, 2007Aug 23, 2011Health Hero Network, Inc.Dynamic modeling and scoring risk assessment
US8015025Nov 15, 2006Sep 6, 2011Health Hero Network, Inc.Method and apparatus for remote health monitoring and providing health related information
US8019618Sep 16, 2003Sep 13, 2011Health Hero Network, Inc.Report generation in a networked health-monitoring system
US8027809Jul 14, 2006Sep 27, 2011Health Hero Network, Inc.Home power management system
US8029245Dec 29, 2008Oct 4, 2011Abbott Diabetes Care Inc.Variable volume, shape memory actuated insulin dispensing pump
US8029250Dec 29, 2008Oct 4, 2011Abbott Diabetes Care Inc.Variable volume, shape memory actuated insulin dispensing pump
US8029459Dec 21, 2009Oct 4, 2011Abbott Diabetes Care Inc.Method and system for providing integrated medication infusion and analyte monitoring system
US8029460Dec 21, 2009Oct 4, 2011Abbott Diabetes Care Inc.Method and system for providing integrated medication infusion and analyte monitoring system
US8036727Jun 2, 2006Oct 11, 2011Glt Acquisition Corp.Methods for noninvasively measuring analyte levels in a subject
US8047811Dec 29, 2008Nov 1, 2011Abbott Diabetes Care Inc.Variable volume, shape memory actuated insulin dispensing pump
US8047812Dec 29, 2008Nov 1, 2011Abbott Diabetes Care Inc.Variable volume, shape memory actuated insulin dispensing pump
US8050729Jun 28, 2005Nov 1, 2011G-Sense Ltd.Devices for continuous measurement of glucose in body fluid
US8078407Feb 2, 2000Dec 13, 2011Health Hero Network, Inc.System and method for identifying disease-influencing genes
US8078431Jul 14, 2006Dec 13, 2011Health Hero Network, Inc.Home power management system
US8089363Feb 7, 2011Jan 3, 2012Abbott Diabetes Care Inc.Method and system for providing data management in data monitoring system
US8095340Jul 14, 2006Jan 10, 2012Health Hero Network, Inc.Home power management system
US8112138Sep 26, 2008Feb 7, 2012Abbott Diabetes Care Inc.Method and apparatus for providing rechargeable power in data monitoring and management systems
US8133178Feb 22, 2006Mar 13, 2012Dexcom, Inc.Analyte sensor
US8140663Jun 13, 2005Mar 20, 2012Health Hero Network, Inc.Networked system for interactive communication and remote monitoring of individuals
US8177716 *Dec 21, 2009May 15, 2012Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US8204566Aug 2, 2007Jun 19, 2012Glt Acquisition Corp.Method and apparatus for monitoring blood constituent levels in biological tissue
US8249894Sep 16, 2003Aug 21, 2012Robert Bosch Healthcare, Inc.Networked remote patient monitoring with handheld devices
US8260630Nov 15, 2005Sep 4, 2012Health Hero Network, Inc.Modular microprocessor-based appliance system
US8290559Oct 24, 2008Oct 16, 2012Dexcom, Inc.Systems and methods for processing sensor data
US8306596Sep 22, 2010Nov 6, 2012Glt Acquisition Corp.Method for data reduction and calibration of an OCT-based physiological monitor
US8343092Nov 24, 2009Jan 1, 2013Abbott Diabetes Care Inc.Method and system for providing integrated medication infusion and analyte monitoring system
US8343093May 28, 2010Jan 1, 2013Abbott Diabetes Care Inc.Fluid delivery device with autocalibration
US8344966Jan 31, 2006Jan 1, 2013Abbott Diabetes Care Inc.Method and system for providing a fault tolerant display unit in an electronic device
US8353827Aug 29, 2006Jan 15, 2013Robert Bosch Healthcare Systems, Inc.Networked system for interactive communication and remote monitoring of individuals
US8407063Aug 25, 2006Mar 26, 2013Robert Bosch Healthcare Systems, Inc.Multi-user remote health monitoring system with biometrics support
US8417312Oct 24, 2008Apr 9, 2013Dexcom, Inc.Systems and methods for processing sensor data
US8467972Apr 28, 2010Jun 18, 2013Abbott Diabetes Care Inc.Closed loop blood glucose control algorithm analysis
US8471714Dec 30, 2011Jun 25, 2013Abbott Diabetes Care Inc.Method and system for providing data management in data monitoring system
US8489428Aug 31, 2006Jul 16, 2013Robert Bosch Healthcare Systems, Inc.Remote health monitoring and maintenance system
US8512246Mar 15, 2010Aug 20, 2013Abbott Diabetes Care Inc.Method and apparatus for providing peak detection circuitry for data communication systems
US8521546Aug 8, 2007Aug 27, 2013Health Hero NetworkDynamic modeling and scoring risk assessment
US8527206Dec 18, 2003Sep 3, 2013Robert Bosch GmbhResearch data collection and analysis
US8548549Sep 9, 2011Oct 1, 2013Glt Acquisition Corp.Methods for noninvasively measuring analyte levels in a subject
US8560082Jan 30, 2009Oct 15, 2013Abbott Diabetes Care Inc.Computerized determination of insulin pump therapy parameters using real time and retrospective data processing
US8571617Mar 4, 2009Oct 29, 2013Glt Acquisition Corp.Flowometry in optical coherence tomography for analyte level estimation
US8579853Oct 31, 2006Nov 12, 2013Abbott Diabetes Care Inc.Infusion devices and methods
US8608653Jun 12, 2006Dec 17, 2013Robert Bosch GmbhNetworked system for interactive communication and remote monitoring of individuals
US8616895Jun 12, 2006Dec 31, 2013Robert Bosch Healthcare Systems, Inc.System and method for monitoring a physiological condition
US8617065Sep 20, 2006Dec 31, 2013Robert Bosch Healthcare Systems, Inc.Networked system for interactive communication and remote monitoring of individuals
US8638220May 23, 2011Jan 28, 2014Abbott Diabetes Care Inc.Method and apparatus for providing data communication in data monitoring and management systems
US8653977Jun 21, 2013Feb 18, 2014Abbott Diabetes Care Inc.Method and system for providing data management in data monitoring system
US8655259Sep 26, 2003Feb 18, 2014Robert Bosch Healthcare Systems, Inc.System and method for monitoring a physiological condition
US8768423Mar 4, 2009Jul 1, 2014Glt Acquisition Corp.Multispot monitoring for use in optical coherence tomography
US8788003Apr 25, 2012Jul 22, 2014Glt Acquisition Corp.Monitoring blood constituent levels in biological tissue
USRE43316Sep 23, 2004Apr 17, 2012Health Hero Network, Inc.Diabetes management system and method for controlling blood glucose
EP2501286A1 Nov 16, 2010Sep 26, 2012Maquet Critical Care ABSelf-flowing measuring system
WO1999051142A2 *Apr 6, 1999Oct 14, 1999Jenny E FreemanNon-invasive tissue glucose level monitoring
WO2001003572A1 *Jul 8, 1999Jan 18, 2001Steffen LeonhardtDevice for measuring the blood-sugar level in humans
WO2009109013A1 *Mar 5, 2009Sep 11, 2009Resmed LtdBlood glucose regulation through control of breathing
Classifications
U.S. Classification600/347, 600/368, 600/534, 604/66
International ClassificationA61B5/00
Cooperative ClassificationA61B5/686, A61B5/14528, A61B5/14532, A61B5/1459
European ClassificationA61B5/145G, A61B5/1459, A61B5/68D1J, A61B5/145F2
Legal Events
DateCodeEventDescription
Mar 9, 1999FPExpired due to failure to pay maintenance fee
Effective date: 19981225
Dec 27, 1998LAPSLapse for failure to pay maintenance fees
Jul 21, 1998REMIMaintenance fee reminder mailed
Jun 24, 1994FPAYFee payment
Year of fee payment: 4